IDEXX Laboratories Stock Is IDXX Underperforming The Healthcare Sector - Barchart
| IX1 Stock | EUR 399.90 4.70 1.16% |
Roughly 62% of IDEXX Laboratories' investor base is looking to short. The analysis of current outlook of investing in IDEXX Laboratories suggests that many traders are alarmed regarding IDEXX Laboratories' prospects. The current market sentiment, together with IDEXX Laboratories' historical and current headlines, can help investors time the market. In addition, many technical investors use IDEXX Laboratories stock news signals to limit their universe of possible portfolio assets.
IDEXX Laboratories stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of IDEXX daily returns and investor perception about the current price of IDEXX Laboratories as well as its diversification or hedging effects on your existing portfolios.
IDEXX |
IDEXX Laboratories Stock Is IDXX Underperforming The Healthcare Sector Barchart
Read at news.google.com
 |
IDEXX Laboratories Fundamental Analysis
We analyze IDEXX Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
IDEXX Laboratories is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
IDEXX Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IDEXX Laboratories stock to make a market-neutral strategy. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with similar companies.
Peers
IDEXX Laboratories Related Equities
| MGK | Magic Software | 5.45 | ||||
| BBEA | Boston Beer | 2.27 | ||||
| TKE | Take Two | 0.89 | ||||
| 0GS | Guidewire Software | 0.21 | ||||
| A9F | Alfa Financial | 0.77 | ||||
| NY70 | MOLSON COORS | 0.89 | ||||
| BBEA | BOSTON BEER | 1.43 |
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |